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Abstract
	
society. 2 CAD, therefore, has become
problem of this country.
The relative risk of developing coronary artery
disease (CAD) in Pakistani men is highest in early ages.
Majority of those suffering from CAD belong to the lower
middle socioeconomic stratum of the society. Mild
hyperhomocysteinemia (concentration of plasma
homocysteine between I5-25 ,umol/I) is very commonly
seen in Pakistani patients with acute myocardial infarction
(AMI) as well as in normal healthy subjects. There appears
to be a lack of association between hyperhomocysteinemia
and CAD in Pakistani population. There is also no evidence
of association of methylenetetrahydrofolate reductase
677C>T mutation with CAD in this population. High
prevalence of deficiency of folate and vitamin B6 appears to
be the major causes of hyperhomocysteinemia in Pakistani
population.
Deficiencies of micronutrients (folate, vitamin 136
and possibly vitamin B 12) along with mild
hyperhomocysteinemia, perhaps, act synergistically with
other classical risk factors in Pakistani population to further
increase the risk of CAD.
Introduction
Coronary artery disease in Pakistan
Pakistani people belong to the South Asian
population which has the highest known rate of coronary
artery disease (CAD).' According to the careful estimates
based on scientific studies nearly 100.000 individuals
suffered from acute myocardial infarction (ANTI) in
calendar year 2002.2 The relative risk of developing CAD
in Pakistani men is highest in early ages. 3 In a recently
published study, 16% of AMI patients at the Aga Khan
University Hospital (AKUH) between 2000-2002 were
found to be younger than 45 years of age and 93% of them
were men. 4 Earlier reports on AMI patients from other
cities of Pakistan presented a similar picture. 5 . 6 In a
relatively larger study, the incidence of AMI was found to
be 192.8/100,000 males during 1994. 7 This figure places
Pakistan at pat= with those countries which have the highest
known rates of CAD. This shows that both intrinsic and
extrinsic factors contribute to the development of CAD in
Pakistani population. Since majority of those suffering from
CAD belong to the lower middle socioeconomic stratum of
the society, it has a devastating impact on the family and the
Homocysteine and atherosclerosis
Homocysteine is a sulfur containing amino acid
which is formed during metabolism of methionine. It is
metabolized by two pathways, remethylation and
transsulfuration. 8 In remethylation, homocysteine acquires
a methyl group either from N 5 , methyltetrahydrofolate (in
all tissues) or from betaine (in liver and kidneys) to form
methionine. The former methylation step requires folate and
vitamin B12 as cofactors: In transsulfuration pathway,
homocysteine condenses with serine to form cystathionine
with the help of a B6-dependent enzyme. Cystathionine is
then enzymatically catabolized to sulfate and excreted in the
urine.	Transsulfuratlon pathw ay i s effective when there is
excess of methionine or cysteine synthesis is required. A
defect in any one of the enzymes involved in these two
pathways or deficiency of folate. vitamin 1312, or vitamin
136 would lead to hyperhomocysteinemia which is now
recognized as an i ndependent risk factor for
atherosclerosis.8
Hyperhomocysteinemia and normal levels of
homocysteine
a major health
Hyperhomoc ysteinemai is usually defined by using
arbitrary cut-off points, for example, above the 95th
percentile or more than two standard deviations above the
mean	v alues	 obtained from fasting normal healthy
subjects.9 Most studies so far have indicated normal plasma
homocysteine level to be in the range from 5 to 15
umol/I.10 1 1 However, this does not imply that there is no risk
associated with homocysteine levels between 10 to 15
i mol/I. Robinson and colleagues have shown that risk for
CAD is represented by a continuum of total homocysteine
concentration, with substantial risk occurring between 10 to
15 Amol/I.12 Perhaps the "desirable level" should be 10
/mol/l or below.
The definition of elevated levels of homocysteine is
not standardized. According to Jacobsen, subjects with
CAD, cerebrovascular disease and peripheral vascular
disease usually present with "mild hyperhomocysteinemia"
(15-25 gmol/I)13, while individuals with homocysteinuria
because of rare inborn errors of homocysteine metabolism
have "severe hyperhomocysteinemia" with homocysteine
concentrations in the range of 50-500 ftmol/I. 14 On the other
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hand, subjects with impaired renal function usually present
with "intermediate hyperhomocysteinemia" with
homocysteine concentrations between 25-50 pmol/I. 1 5
Hyperhomocysteinemia and coronary artery disease
CAD leading to AMI or angina arises because of a
combination of atherosclerosis and thrombosis.
Homocysteine has been found to induce endothelial cell
damage, oxidize low-density lipoprotein and stimulate
smooth muscle cell proliferation. 1 6 Through these effects, it
has been shown to be associated with development of
atherosclerosis. In addition, high concentration of
homocysteine has been found to enhance thrombogenesis
by increasing the activities of factor XII and factor V
depressing the activation of protein C, inhibiting the
expression of thrombomodulin and suppressing the
expression of heparan sulfate by endothelium. 1 6,17
Association of homocysteine with both of these
pathological processes (atherosclerosis and thrombosis)
makes it a potential risk factor for CAD. While, several
case-control studies have provided consistent evidence of
the role of homocysteine as a risk factor for CAD, quite a
few have also shown a complete lack of association between
the two . 1 6,17 The Hordaland Homocysteine Study,
involving more than 12,000 subjects showed that elevated
plasma homocysteine level was associated with major
components of cardiovascular risk profile, such as, male
sex, old age, smoking, high blood pressure, elevated
cholesterol level and lack of exercise.'s More recently, Wald
et al have provided evidence that the association between
homocysteine and cardiovascular disease is causal and
lowering homocysteine concentration by 3 umol/I from
current levels through folic acid supplementation, would
reduce the risk of ischaemic heart disease by 16%.19
Hyperhomocysteinemia and CAD in Pakistan
So far 3 studies have been published regarding
hyperhomocysteinemia and CAD in Pakistan.20 22 While
studies by Salahuddin et aI 20 and Aamir et al 2 l have reported
positive association between elevated plasma homocysteine
and CAD, a recent study from the AKUH laboratory
showed lack of association between hyperhomocysteinemia
and CAD in a Pakistani population of patients with AMI 22
The difference appears to be due to the design of the studies,
size of the population, and socioeconomic background of
the subjects. Mean plasma homocysteine levels in AM]
patients and controls in the studies by Salahuddin et al,
Aamir et al and Iqbal et al were 14.97±1.13 pmol/I,
10.57±0.31 umol/l, 18±5.9 umol/I, 1 0.8±4.1 umol/I,
18±8.36 umol/I and 16.4±4.9 u mol/I, respectively. While
mean concentration values of plasma homocysteine in AMI
patients in 3 studies were not statistically different (p=0.09),
mean concentration of homocysteine in controls (16.4±4.9
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umol/I) in the AKUH study was significantly different from
the values reported in the other two studies (p=0.0001).
This could be due to the fact that AKUH study matched the
controls with cases not only on the basis of age and gender
but also on socio-economic background. Moreover, those
taking B-complex vitamin (folate, B12 and 136)
supplements during the last six months were excluded from
the study. One third (32.5%) and almost half (49%) of the
controls were folate-deficient and B6-deficient respectively.
Compared to folate-normal individuals (AMI patients as
well as controls), folate-deficient and B6-deficient subjects
were having significantly (P<0.002) elevated levels of
plasma homocysteine indicating a positive association
between deficiency of folate and B6 and
hyperhomocysteinemia in Pakistani population. 22 This is in
line with the observation of Selhub and colleagues that
i nadequate plasma concentrations of one or more B
vitamins contribute to approximately two thirds of all cases
of hyperhomocysteinemia. 23
Nutritional deficiciency of B-vitamins, therefore,
appears to be the major cause of hyperhomocysteinemia in
Pakistani population. Such high plasma levels of
homocysteine in normal healthy subjects are not unique to
our population. Similar high levels of plasma homocysteine
i n normal controls have also been reported in certain
populations in South India (18±10.7 umol/I)24 , Thailand
(19.9±8.1 umol/I)25, Turkey (15.6±10 Amol/I) 26 , and Syria
(14±6.2 umol/I in males and 11.2±3.6 u mol/l in females). 27
In another study conducted on population from Karachi and
Rawalpindi involving 397 AMI patients and 225 normal
healthy controls, mild hyperhomocysteinemia (mean
concentration of homocysteine about 17 umol/I) was found
in both patient and control groups with hardly any
difference between the two mean homocysteine values.28
The results of this study further substantiate AKUH initial
observation regarding lack of association between
hyperhomocysteinemia and CAD in Pakistani population.
Factors causing hyperhomocysteinemia in Pakistani
population
Elucidation of the mechanism of
hyperhomocysteinemia in Pakistani population is one of the
major challenges for the local scientific community. Both
i ntrinsic and extrinsic factors will have to be taken into
account. An enzyme, 5, 10-methylenetetrahydrofol ate
reductase
( MTHFR), _catalyzes- the formation
of 5-methyl tetrahydrofolate which is involved in the methylation
of homocysteine to methionine. 9 Another local study have
recently shown l ack of association of
methylenetetrahydrofolate reductase 677C > T mutation
with CAD in Pakistani population. 28 The frequency of
homozygous mutant gene which is associated with
28 3
hyperhomocysteinemia in most populations appears to be
quite low (2% in AMI patients and 3% in normal healthy
subjects) in Pakistani population.28 Therefore, mild
hyperhomocysteinemia observed in Pakistani AMI patients
and normal controls, appears unlikely to be due to 677C >
T mutation in MTHFR gene. Role of other mutations in
MTHFR, however, cannot be discounted in Pakistani
population.29 Mutations in vitamin B12-dependent
methionine synthtase have been identified, however, the
prevalence of these mutations in general population and
their contribution to hyperhomocysteinemia i n
heterozygous individuals is still not known. 1 3 Similarly, in
the gene for vitamin B6-dependent cystathionine B-synthase
nearly 40 mutations have been identified, but the role of
cystathionine B-synthase polymorphism in atherosclerosis
remains to be determined. 1 3
High prevalence of deficiency of folate and vitamin
B6 appears to be the major cause of hyperhomocysteinemia
i n Pakistani population. The deficiency of these vitamins
could be due to lower intake of fresh fruits and vegetables,
overcooking of our food and a high prevalence of parasitic
enteric infections (especially amoebiasis and giardiasis) in
our population. 30 In addition to these, there could be other
factors, yet unknown, affecting various enzymes of
remethylation and transsulfuration pathways of
homocyteine metabolism leading to hyperhomocysteinemia
i n Pakistani population.
So far, no large scale "community-based" studies
have been conducted to assess the prevalence of folate,
vitamin B6 and B12 deficiencies in Pakistan. In the absence
of these studies, it would be difficult to ascertain the
enormity of the problem due to these micronutrients
deficiency in our general population. A recent local study
showed a causal relationship between nutritional deficiency
of folate, B12 and B6 and AMI in our population.'-'-
Whether this association i s through "mild
hyperhomocysteinemia" (observed in our population) or
not, remains to be ascertained.
It is possible that deficiencies of micronutrients
along with mild hyperhomocysteinemia could be acting
synergistically with other highly prevalent classical risk
factors, such as, low HDL-cholesterol,
hypercholesterol emia, hypertriglyceridemia, hypertension,
diabetes mellitus; waist-hip ratio, obesity, tobacco use,
parental history of ischaemic heart disease etc., thereby,
further increasing the risk of CAD in Pakistani
population. 1 -31-35 There is a need for supplementation trials
at the community level with folate, vitamin B6 and possibly
vitamin B 12 to lower the high levels of homocysteine
followed by assessment of the impact of this intervention on
28 4
Conclusion
the development of CAD in our population.
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Angiokeratoma of tongue: a series of 14 cases
Nausheen Yaqoob, Aamir Ahsan, Zubair Ahmed, Akhter Husain, Rashid Ahmed, Naila Kayani,
Shahid Pervez, Sheema Hassan
Department of Pathology,
Abstract
Angiokeratomas (AC) are vascular lesions which are
defined histologically as one or more dilated blood vessels
l ying directly subepidermal and showing an epidermal
proliferative reaction with ectatic capillaries in the papillary
dermis. Only three other cases of i solated mucosal
angiokeratoma have been reported in the indexed literature.
We reviewed all cases of angiokeratoma located on the
tongue, diagnosed in our department during a study period
of 10 years (1995-2005).
Histologically all I4 cases showed dilated and
congested blood vessels in the upper papillary dermis. They
lack deep dermal involvement. Hyperkeratosis and
acanthosis were also seen in most of the cases. No clinical
data was available to assess systemic disease, A higher
incidence of of AC in tongue is seen in our study.
Introduction
Angiokeratomas (AC) represent ectasia of
superficial blood vessels associated with secondary
epidermal changes, especially acanthosis and
hyperkeratosis. Five variants have been described.' They
are: 1) the generalized systemic type-angiokeratoma
colporis diffusum of Fabry; 2) multiple papular, and plaque
like - angiokeratoma circumscriptum (naeviforme); 3) the
bilateral form occurring on the dorsal areas of the fingers
and toes- angiokeratoma of mibelli; 4) angiokeratoma of
Fordyce- the localized scrotal form; and 5) solitary papular
angiokeratoma, although usually single, multiple lesions
may occur between the age of 10 and 40 years and the legs
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are the site of predilection. Multiple lesions have been
reported in zosteriform distribution. 2 Association of
angiokeratoma circumscriptum with angiokeratoma of the
scrotum3,4 angiodysplasia (Klipple-Trenaunay-Weber
syndrome) Cobb syndrome, and other mixed vascular
malformations have been reported. 1 .5
Methods and Results
We reviewed all cases of AC located on the tongue
(n=14) diagnosed in our department during a study period
of 10 years (1995-2005). Location of the lesions was tip of
tongue in 2 cases, anterior two third in 2 cases, posterior one
third in 2 cases, dorsum of tongue in I case and location was
not mentioned in 7 cases. t o 2 cases, the clinical cluer\ \\ ll,
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